🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
10.89
-0.43 (-3.80%)
Nov 20, 2026, 3:04 PM CST

SHE:002020 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
709.48757.98711.96618.9662.25612.54
Depreciation & Amortization
281.14281.14295.28219.95166.87149.92
Other Amortization
21.5621.5615.4911.5533.0832.6
Loss (Gain) From Sale of Assets
0.570.57-2.59-6.86-0.610.48
Asset Writedown & Restructuring Costs
15.6915.690.070.010.078.42
Loss (Gain) From Sale of Investments
-26.58-26.5833.41-30.88-29.57-55.39
Provision & Write-off of Bad Debts
6.166.1613.166.733.6410.8
Other Operating Activities
207.346.8426.215.63-1.322.77
Change in Accounts Receivable
-26.57-26.57-249.65-93.48-250.89-208.58
Change in Inventory
-5.23-5.23-152.84123.04-102.95-152.51
Change in Accounts Payable
-258.73-258.7352.3-74.58387.41-41.84
Change in Other Net Operating Assets
-0.44-0.44----
Operating Cash Flow
933.35781.35726.16792.84855.78373.46
Operating Cash Flow Growth
28.04%7.60%-8.41%-7.36%129.15%-27.23%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-195.9-202.85-250.65-519.51-515.57-406.83
Sale of Property, Plant & Equipment
4.423.895.210.271.992.93
Investment in Securities
-559.32538.91-1,240-260.2-342.4508.33
Other Investing Activities
72.6427.1647.8631.85118.3237.86
Investing Cash Flow
-678.16367.11-1,438-737.59-737.66142.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-566.98738.29---
Long-Term Debt Issued
---585236.54146.16
Total Debt Issued
469.18566.98738.29585236.54146.16
Short-Term Debt Repaid
--567-742---
Long-Term Debt Repaid
--17.06-15.56-568.33-166.05-320.64
Lease Payments
-17.06-17.06-15.56-18.33-16.05-15.43
Total Debt Repaid
-497.06-584.06-757.56-568.33-166.05-320.64
Net Debt Issued (Repaid)
-27.88-17.08-19.2716.6770.49-174.48
Issuance of Common Stock
-----515.56
Repurchase of Common Stock
-608.78-608.78----
Common Dividends Paid
-284.82-284.85-258.31-258.31-258.56-232.17
Other Financing Activities
581.76-5.03-2.58-3.970.044.47
Financing Cash Flow
-339.72-915.75-280.16-245.61-188.03113.38

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-26.01-7.222.992.7114.87-3.75
Net Cash Flow
-110.54225.49-988.87-187.65-55.05625.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
737.45578.5475.52273.32340.2-33.37
Free Cash Flow Growth
47.02%21.66%73.98%-19.66%--
Free Cash Flow Margin
18.18%14.22%11.43%6.83%9.00%-0.96%
Free Cash Flow Per Share
0.900.700.550.320.40-0.04
Levered Free Cash Flow
1,202-335.72539.05-85.08312.3-204.19
Unlevered Free Cash Flow
1,203-333.24543.89-80.51316.06-201.08
Free Cash Flow After Leases
720.4561.44459.95254.99324.15-48.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
341.59306.67260.88245.5262.09231.14
Change in Working Capital
-282.02-282.02-366.83-42.1821.35-408.69